for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Perrigo Company PLC

PRGO.N

Latest Trade

43.94USD

Change

-0.34(-0.77%)

Volume

14,024,288

Today's Range

43.67

 - 

45.12

52 Week Range

38.20

 - 

49.90

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
44.28
Open
44.11
Volume
14,024,288
3M AVG Volume
30.77
Today's High
45.12
Today's Low
43.67
52 Week High
49.90
52 Week Low
38.20
Shares Out (MIL)
133.71
Market Cap (MIL)
5,920.89
Forward P/E
17.82
Dividend (Yield %)
2.17

Next Event

Q3 2021 Perrigo Company PLC Earnings Release

Latest Developments

More

Perrigo To Acquire Consumer Self-Care Company, HRA Pharma

Perrigo Reports Second Quarter 2021 Financial Results

Perrigo Company Says Co's Cep Met With The Irish Times To Discuss Transformation To Pure-Play Consumer Self-Care Company

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Perrigo Company PLC

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.

Industry

Personal Services

Contact Info

The Sharp Building

Hogan Place, Dublin 2

D02 TY74

Ireland

+353.1.7094000

https://www.perrigo.com/

Executive Leadership

Rolf A. Classon

Independent Chairman of the Board

Murray S. Kessler

President, Chief Executive Officer, Director

Raymond P. Silcock

Chief Financial Officer, Executive Vice President

Robert Willis

Chief Human Resource Officer, Executive Vice President

Thomas M. Farrington

Executive Vice President, Chief Information Officer

Key Stats

2.80 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

4.7K

2019

4.8K

2020

5.1K

2021(E)

4.2K
EPS (USD)

2018

4.550

2019

4.030

2020

4.160

2021(E)

2.485
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.32
Price To Book (MRQ)
1.07
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
64.52
LT Debt To Equity (MRQ)
53.09
Return on Investment (TTM)
-4.50
Return on Equity (TTM)
-3.76

Latest News

Latest News

Wall Street ends lower, weighed down by Big Tech

Wall Street ended lower on Wednesday, spooked by worries that the Delta coronavirus variant could blunt the economy's recovery and on uncertainty about when the Federal Reserve may pull back its accommodative policies.

US STOCKS-Wall Street ends lower, weighed down by Big Tech

* PayPal falls after acquiring Japanese buy now, pay later firm (Updates with end of session)

US STOCKS-Big Tech tugs Wall Street back from record high levels

* PayPal falls after acquiring Japanese buy now, pay later firm

US STOCKS-Wall Street falls as growth worries grip investors

* PayPal falls after acquiring Japanese buy now pay later firm

Perrigo to buy HRA Pharma in $2.1 billion deal to expand self-care portfolio

Perrigo Company Plc said on Wednesday it would buy HRA Pharma from investment firms Astorg and Goldman Sachs Asset Management in a deal valued at 1.8 billion euros ($2.13 billion) to bolster its over-the-counter self-care offerings, sending its shares up 6%.

US STOCKS-Wall Street dips on fears of slowing economic growth

* Indexes down: Dow 0.03%, S&P 0.07%, Nasdaq 0.28% (Updates to open)

US STOCKS-Wall St set to open flat on fears over slowing economic growth

* Oil stocks gain on higher crude prices (Updates prices, adds comment)

Perrigo to buy HRA Pharma in $2.1 bln deal

Perrigo Company Plc said on Wednesday it plans to buy consumer self-care company HRA Pharma in a deal valued at 1.8 billion euros ($2.13 billion). ($1 = 0.8461 euros) (Reporting by Amruta Khandekar; Editing by Vinay Dwivedi)

US STOCKS-Wall Street falls on worries over slowing economic recovery

* Indexes down: Dow 0.72%, S&P 0.42%, Nasdaq 0.02% (Updates to open)

US STOCKS-Wall Street to open flat as Delta variant weighs on recovery

* Futures: Dow and S&P flat, Nasdaq up 0.05% (Updates prices, adds comment)

U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug

The U.S. Supreme Court on Monday declined to hear AbbVie Inc's challenge to a lower court's decision that it violated federal antitrust law by pursuing a "sham" patent complaint against rival Perrigo Co over AbbVie's blockbuster testosterone replacement drug AndroGel.

U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug

The U.S. Supreme Court on Monday declined to hear AbbVie Inc's challenge to a lower court's decision that it violated federal antitrust law by pursuing a "sham" patent complaint against rival Perrigo Co over AbbVie's blockbuster testosterone replacement drug AndroGel.

S&P 500 surges in strongest one-day rise since June

The S&P 500 surged on Monday in its strongest one-day gain since June as bond markets calmed after a month-long selloff, while another COVID-19 vaccine getting U.S. approval and fiscal stimulus bolstered expectations of a swift economic recovery.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 1810 GMT on Monday:

US STOCKS-Wall Street rallies as Treasury yields stabilize

* Cyclical energy, banks, materials stocks jump (Updates with close of trading)

US STOCKS-S&P 500 rallies, on track for best one-day rise since June

* Indexes: Dow +2.30%, S&P 500 +2.55%, Nasdaq +2.80% (Adds detail on market, comment from strategist)

US STOCKS-S&P 500 set for best day in nine months on vaccine, stimulus cheer

* Indexes up: Dow 2.22%, S&P 2.27%, Nasdaq 2.41% (Adds comment, details; updates prices)

CORRECTED-US STOCKS-Wall St jumps on J&J vaccine cheer, stimulus optimism

Wall Street's major averages rose 1.5% on Monday as bond markets calmed after a month-long selloff, while encouraging updates on the vaccine and stimulus fronts strengthened bets over a swift economic recovery.

US STOCKS-Wall St set for higher open on J&J vaccine cheer, stimulus optimism

* Futures up: Dow 1%, S&P 1.1%, Nasdaq 1.5% (Adds comment, details; updates prices)

Perrigo to sell generic drugs business for $1.55 billion

Perrigo Company Plc on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up